Merck KGaA (OTCMKTS:MKGAF) Shares Gap Up – Still a Buy?

Merck KGaA (OTCMKTS:MKGAFGet Free Report)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $139.63, but opened at $147.47. Merck KGaA shares last traded at $139.23, with a volume of 217 shares.

Merck KGaA Price Performance

The company’s 50 day simple moving average is $135.80 and its 200 day simple moving average is $132.69. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock has a market cap of $19.06 billion, a P/E ratio of 22.51 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.

See Also

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.